IP Library Granted Patent US 8,877,034
Granted Patent B2
US 8,877,034 · App. 12/649,509 · Granted Nov 4, 2014

Systems, devices, and methods for measuring whole blood hematocrit based on initial fill velocity

Inventors: Ronald C. Chatelier (Bayswater, AU); Dennis Rylatt (Wheelers Hill, AU); Linda Raineri (Prahran, AU); Alastair M. Hodges (Blackburn, AU)
Assignee: LifeScan, Inc.
G01N33/80G01N27/48G01N33/49
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,877,034
App. No.
12/649,509
Filed
Dec 30, 2009
Granted
Nov 4, 2014
Kind
B2
Art Unit
1759
USPC
205/777.5
Abstract

Methods for determining the hematocrit of a blood sample, and devices and systems used in conjunction with the same. The hematocrit value can be determined on its own, and further, it can be further used to determine a concentration of an analyte in a sample. In one exemplary embodiment of a method for determining the hematocrit value in a blood sample, a volume of blood is provided in a sample analyzing device having a working and a counter electrode. An electric potential is applied between the electrodes and an initial fill velocity of the sample into the device is calculated. The hematocrit of the blood, as well as a concentration of an analyte in view of the initial fill velocity can then be determined. Systems and devices that take advantage of the use of an initial fill velocity to determine hematocrit levels and make analyte concentration determinations are also provided.

Claims (74)

1. A method for determining an analyte of a whole blood sample, the method comprising the steps of:

providing a sample of whole blood to a sample analyzing device having a capillary space;

measuring an initial fill velocity of the sample in at least a portion of the capillary space in which the initial velocity is measured by:

applying an electrical potential;

measuring an electrical current; and

determining an initial current flow;

determining a hematocrit value of the blood sample solely from the measured initial fill velocity using an equation that requires the determined initial current flow and wherein the sample includes an analyte, and

calculating a concentration of the analyte by:

applying an electric potential;

measuring an initial current after applying the electric potential;

reversing the electric potential;

measuring a change in current over time following the reversal of the electric potential as a slope (m) of a current versus time graph; and

using an equation that requires the determined hematocrit value and the measured change in current over time.

2. The method of claim 1 , wherein the step of measuring an initial fill velocity further comprises the additional steps of:

performing current measurements approximately every 10 milliseconds for at least approximately 50 milliseconds; and

calculating an average current based on the current measurements.

3. The method of claim 1 , wherein the step of measuring an initial fill velocity of the sample occurs after the sample enters the capillary space.

4. The method of claim 1 , wherein the step of measuring an initial fill velocity of the sample occurs after the sample crosses into a region of the capillary space of the sample analyzing device where a detection signal is generated.

5. The method of claim 1 , further comprising the step of at least one of measuring a temperature of the sample and inferring a temperature of the sample.

6. The method of claim 1 , wherein the sample analyzing device is an immunosensor.

7. The method of claim 1 , further comprising the step of at least one of measuring a temperature of the sample and inferring the temperature of the sample.

8. The method of claim 7 , further comprising the step of measuring a change in current over a period of time after the step of reversing the electric potential, wherein the step of calculating a concentration of the analyte comprises the additional step of calculating the concentration of the analyte in view of the change in current over the period of time and the temperature of the sample.

9. The method of claim 1 , wherein the equation for determining the hematocrit value is

H= 97.6−1.7658| i i |

in which |i i | is the absolute value of the initial current.

10. The method of claim 5 , including the equation for determining the hematocrit value is

H= 77.1−2.1| i i |+0.75T

in which |i i | is the absolute value of the initial current and T is the temperature of the sample.

11. The method of claim 1 , in which the equation for determining analyte concentration is C O =−3.5+0.866 exp(y)

in which C O is the concentration of analyte and

y

=

m

(

1

-

0.01

H

)

0.83

in which m is the slope of the current versus time curve, and H is the determined hematocrit value.

12. The method of claim 8 , in which the equation for determining analyte concentration is C O =−5.7+1.78 exp(y′)

in which C O is the concentration of the analyte and

y

=

y

1

+

0.068

(

T

-

25

)

,

in which T is the temperature of the sample and

y

=

m

(

1

-

0.01

H

)

1.55

and

m is the slope of a current versus time curve and H is the determined hematocrit value.

Assignments (18)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 18, 2026
From: LIFESCAN GLOBAL CORPORATION; LIFESCAN CHINA, LLC; LIFESCAN IP HOLDINGS, LLC
To: LIFESCAN ENTERPRISES LLC
Reel/Frame 075848/0012 →
RELEASE OF SECURITY INTEREST Recorded Dec 8, 2025
From: ANKURA TRUST COMPANY, LLC
To: LIFESCAN IP HOLDINGS, LLC
Reel/Frame 073929/0495 →
SECURITY INTEREST Recorded Dec 8, 2025
From: LIFESCAN ENTERPRISES LLC
To: ACQUIOM AGENCY SERVICES LLC, AS COLLATERAL AGENT
Reel/Frame 073890/0305 →
SECURITY AGREEMENT Recorded Dec 8, 2025
From: LIFESCAN ENTERPRISES LLC
To: WELLS FARGO BANK, NATIONAL ASSOCIATION
Reel/Frame 073893/0622 →
RELEASE OF SECURITY INTEREST Recorded Dec 8, 2025
From: WILMINGTON SAVINGS FUND SOCIETY, FSBWILMINGTON SAVINGS FUND SOCIETY, FSB
To: LIFESCAN IP HOLDINGS, LLC
Reel/Frame 073928/0626 →
RELEASE OF SECURITY INTEREST Recorded Dec 8, 2025
From: WILMINGTON SAVINGS FUND SOCIETY, FSB
To: LIFESCAN IP HOLDINGS, LLC
Reel/Frame 073929/0316 →
ASSIGNMENT OF PATENT SECURITY INTERESTS (1ST LIEN) Recorded Aug 22, 2025
From: BANK OF AMERICA, N.A.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SUCCESSOR AGENT
Reel/Frame 072567/0482 →
TRANSFER OF SECURITY AGREEMENT RECORDED AT REEL 063740, FRAME 0080 Recorded Nov 12, 2024
From: BANK OF AMERICA, N.A., AS RESIGNING AGENT
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SUCCESSOR AGENT
Reel/Frame 069340/0243 →
TRANSFER OF SECURITY AGREEMENT RECORDED AT REEL 047179, FRAME 0150 Recorded Nov 11, 2024
From: BANK OF AMERICA, N.A., AS RESIGNING AGENT
To: ANKURA TRUST COMPANY, LLC, AS SUCCESSOR AGENT
Reel/Frame 069314/0022 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PROPERTY LIST BY ADDING PATENTS 6990849;7169116; 7351770;7462265;7468125; 7572356;8093903; 8486245;8066866;AND DELETE 10881560. PREVIOUSLY RECORDED ON REEL 050836 FRAME 0737. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Aug 28, 2023
From: LIFESCAN INC.
To: CILAG GMBH INTERNATIONAL
Reel/Frame 064782/0443 →
RELEASE OF SECOND LIEN PATENT SECURITY AGREEMENT RECORDED OCT. 3, 2018, REEL/FRAME 047186/0836 Recorded Jun 28, 2023
From: BANK OF AMERICA, N.A.
To: LIFESCAN IP HOLDINGS, LLC; JANSSEN BIOTECH, INC.; JOHNSON & JOHNSON CONSUMER INC.
Reel/Frame 064206/0176 →
SECOND LIEN PATENT SECURITY AGREEMENT Recorded May 23, 2023
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A.
Reel/Frame 063740/0080 →
FIRST LIEN PATENT SECURITY AGREEMENT Recorded May 22, 2023
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A.
Reel/Frame 063712/0430 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2019
From: LIFESCAN INC.
To: CILAG GMBH INTERNATIONAL
Reel/Frame 050836/0737 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2019
From: CILAG GMBH INTERNATIONAL
To: LIFESCAN IP HOLDINGS, LLC
Reel/Frame 050837/0001 →
SECURITY AGREEMENT Recorded Oct 3, 2018
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 047186/0836 →
SECURITY AGREEMENT Recorded Oct 2, 2018
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 047179/0150 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 22, 2010
From: CHATELIER, RONALD C.; RYLATT, DENNIS; RAINERI, LINDA; HODGES, ALASTAIR M.
To: LIFESCAN, INC.
Reel/Frame 024115/0174 →
Continuity (1)
Related Publication 20110155584A1 · Jun 30, 2011